Haleon plc
HLN
Rank in Stocks
#13724
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Share Price
$5.08
Last synced: 2026-10-16
Market Cap
$447.23M
Change (1 day)
-0.11%
Change (1 year)
7.96%
Country
GB
Trade Haleon plc (HLN)
Category
Healthcare
Market Capitalization of Haleon plc(HLN)
Market Cap: $447.23M
As of October 2026 Haleon plc has a market cap of $447.23M. This makes Haleon plc the world's 13724th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Haleon plc from 2022 to 2026
